FdaApplication
ANDA 209093
Identifiers
- fda_app_no: ANDA209093
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2017-05-17 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE;ORAL |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE;ORAL |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE;ORAL |
3 products